1 results match your criteria: "Larrey Hospital and Institut Universitaire du Cancer[Affiliation]"
Enzalutamide induced acute generalized exanthematous pustulosis.
J Dermatol Case Rep
November 2016
Paul Sabatier University, Department of Dermatology, Larrey Hospital and Institut Universitaire du Cancer, Toulouse, France.
Introduction: (Xtandi®) is a new potent inhibitor of the signaling pathway for the androgen receptor with a half-life of 5.8 days. It has been on the market for the treatment of metastatic castration-resistant prostate cancer since November 2013.
View Article and Find Full Text PDF